Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 1,205,700 | 1,033,500 | 981,300 | 821,400 | 672,000 |
| Total expenses | 1,166,400 | 993,400 | 914,300 | 731,700 | 647,900 |
| Operating Income | 39,300 | 40,100 | 67,000 | 89,700 | 24,100 |
| Interest Expense | 64,600 | 57,700 | 82,000 | 94,700 | 68,100 |
| Other Income | 45,700 | 55,400 | 52,700 | 6,800 | -36,500 |
| Pre-tax Income | 20,400 | 37,800 | 37,700 | 1,800 | -80,500 |
| Income Tax | -4,900 | -3,600 | -3,700 | 600 | 3,000 |
| Net Income Continuous | 25,300 | 41,400 | 41,400 | 1,200 | -83,500 |
| Net Income | $25,300 | $41,400 | $41,400 | $1,200 | $-83,500 |
| EPS Basic Continuous Ops | 0.20 | 0.35 | 0.37 | 0.01 | -0.94 |
| EPS Basic Total Ops | 0.20 | 0.35 | 0.36 | 0.00 | -0.95 |
| EPS Diluted Continuous Ops | 0.20 | 0.35 | 0.37 | 0.01 | -0.94 |
| EPS Diluted Total Ops | 0.20 | 0.35 | 0.36 | 0.00 | -0.95 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.35 | -0.01 | 0.00 | -0.95 |
| EBITDA(a) | $546,300 | $496,300 | $489,700 | $427,800 | $287,200 |